Related Experiment Video
Updated: Jul 13, 2026

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
Published on: May 16, 2025
[Drug-induced agranulocytosis in rheumatology. A retrospective study of 12 cases]
K Serraj1, L Federici, F Maloisel
1Service de médecine interne, diabète et maladies métaboliques, Clinique médicale B, CHRU de Strasbourg. s@chru-strasbourg.fr
Objective:
the aim of this study is to determine the clinical characteristics of drug-induced agranulocytosis in rheumatology.
Patients And Method:
it is a retrospective monocentric study, including all cases of rheumatologic drug-induced agranulocytosis followed between January 1985 and December 2005.
Results:
eight female and 4 men, mean age 62.5 years (range: 17-79), were included in the present study. The causative drugs were: anti-inflammatory agents (n=5, 41.6%), methotrexate (n=3, 25%), sulfasalazine (n=2, 16.6%), noramidopyrine (n=1) and dapsone (n=1). Main clinical features included infectious disorders in 9 cases (75%) with 4 cases of septicemia (33.3%) and 2 cases of septic shock (16.6%). The mean neutrophils count was 0.132 x 10(9)/L (range, 0-0.4). Outcome was favorable in 11 patients (91.6%). One patient died of septic complications.
Conclusion:
in rheumatology, drug-induced agranulocytosis is a rare but life-threatening disorder.
Related Concept Videos
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Rheumatic Heart Disease I: Introduction
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
